Samsung Biologics to acquire Biogen's stake in Samsung Bioepis
Is Samsung really 'at negotiating table' for Biogen? What we know so far - MM+M
Samsung s'associe à Biogen Idec
Samsung intéressé par le rachat du laboratoire Biogen | La Presse
Samsung intéressé par le rachat du laboratoire Biogen pour plus de $40 milliards | Arab News FR
Samsung Biologics buys out Biogen in biosim venture for US$2.3B | HealthCare Middle East & Africa Magazine
Le numérique, indispensable au développement des biosimilaires de Samsung Bioepis - mind Health
Samsung Wants to Buy Biogen • BioPharma Media
Le bénéfice de Biogen fait plus que doubler suite à la vente de la participation de Samsung Bioepis -Le 20 juillet 2022 à 13:09 | Zonebourse
Merck to develop biosimilars with Samsung-Biogen joint venture - PMLiVE
Biogen and Samsung Bioepis present data for Infliximab and Adalimumab biosimilars - Hub Publishing
Biosimilaires : Biogen se déleste de Samsung Bioepis
Samsung Bioepis looks to acquire Biogen's biosim unit: reports
Samsung Bioepis seeks to buy Biogen biosimilar unit - KED Global
Les ventes en Europe des biosimilaires de Samsung Bioepis grimpent de 13% au T3 | AGENCE DE PRESSE YONHAP
Biosimilaires : Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen | MyPharma Editions
Biogen sells stake in Samsung venture for $2.3 billion - STAT
Samsung BioLogics says report on Biogen deal talks untrue | Fox Business
Samsung in Talks to Buy Alzheimer's Drug Maker Biogen for $42 Billion: Report | Technology News
Company News | Newsroom | SAMSUNG BIOLOGICS
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Samsung Biologics Buys Bioepis Stake for $2.3 Billion From Biogen - Bloomberg
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million | BioSpace
